AI in Drug Discovery: How Amgen Uses AI to Design Proteins
See how Amgen scientists are using AI to understand proteins and accelerate the development of new medicines. Artificial intelligence (AI) and machine learning (ML) are transforming how we discover and design new medicines. At Amgen, scientists use AI-driven protein language models to analyze vast amounts of protein data – revealing the hidden relationships between a protein’s sequence, structure and function. These insights accelerate drug discovery, reduce costly lab work and help bring the next generation of Amgen therapeutics to patients faster. By combining AI, machine learning and protein language models, Amgen researchers can generate deeper protein insights and support more efficient drug discovery workflows. This approach helps advance innovative therapeutics for patients worldwide. #Amgen #AI #DrugDiscovery #MachineLearning #GenerativeAI #GenerativeBiology Find Amgen on the Web: Facebook: https://bit.ly/35Xf09E Instagram: https://bit.ly/2SYnTKJ X: https://bit.ly/2SW2cLq LinkedIn: https://bit.ly/2xWbS17

AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research

Welcome to Amgen Dún Laoghaire ADL - Biologic Medicine Manufacturing

Omics in Drug Discovery: How Amgen Uses Omics to Understand Disease

Advancing Obesity Research

Amgen Operations: Learn More About Our Passion And Process

DNA-Encoded Libraries in Drug Discovery: How Amgen Uses DEL Technology to Find New Medicines

The Challenges in Manufacturing Biologics

Inside Amgen’s Next-Generation Labs | Faster, Smarter Small Molecule Drug Discovery

The Evolution of Biotechnology – The Arrival of Biosimilars

Working at Amgen

The Next Generation of Biomanufacturing at Amgen

Fighting the World's Toughest Diseases

How Biosimilars Are Made: Inside Biologic Drug Manufacturing

Discovering What is Not Yet Known

